About Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical & Diagnostic Laboratories
- Sub-Industry: N/A
- Symbol: NASDAQ:PMD
- CUSIP: N/A
- Web: www.psychemedics.com
Capitalization:- Market Cap: $95.39 million
- Outstanding Shares: 5,491,000
Average Prices:- 50 Day Moving Avg: $18.92
- 200 Day Moving Avg: $21.24
- 52 Week Range: $13.81 - $27.99
P/E:- Trailing P/E Ratio: 12.82
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: $42.51 million
- Price / Sales: 2.22
- Book Value: $2.99 per share
- Price / Book: 5.74
Dividend:- Annual Dividend: $0.60
- Dividend Yield: 3.5%
Profitability:- EBITDA: $13.84 million
- Net Margins: 17.59%
- Return on Equity: 47.94%
- Return on Assets: 29.82%
Debt:- Debt-to-Equity Ratio: 0.06%
- Current Ratio: 3.00%
- Quick Ratio: 3.00%
Misc:- Average Volume: 42,011 shs.
- Beta: 1
- Short Ratio: 0.91
Frequently Asked Questions for Psychemedics Corporation (NASDAQ:PMD)
What is Psychemedics Corporation's stock symbol?
Psychemedics Corporation trades on the NASDAQ under the ticker symbol "PMD."
How often does Psychemedics Corporation pay dividends? What is the dividend yield for Psychemedics Corporation?
Psychemedics Corporation declared a quarterly dividend on Thursday, August 3rd. Investors of record on Monday, August 14th will be given a dividend of $0.15 per share on Thursday, August 24th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.50%. The ex-dividend date is Thursday, August 10th. View Psychemedics Corporation's Dividend History.
How were Psychemedics Corporation's earnings last quarter?
Psychemedics Corporation (NASDAQ:PMD) posted its quarterly earnings results on Wednesday, August, 2nd. The company reported $0.16 earnings per share for the quarter. The firm had revenue of $9.68 million for the quarter. Psychemedics Corporation had a net margin of 17.59% and a return on equity of 47.94%. View Psychemedics Corporation's Earnings History.
When will Psychemedics Corporation make its next earnings announcement?
Who are some of Psychemedics Corporation's key competitors?
Some companies that are related to Psychemedics Corporation include Cogentix Medical (CGNT), Anavex Life Sciences Corp. (AVXL), Merrimack Pharmaceuticals (MACK), Cytosorbents Corporation (CTSO), Kamada (KMDA), XOMA Corporation (XOMA), Peregrine Pharmaceuticals (PPHM), Ocular Therapeutix (OCUL), Marinus Pharmaceuticals (MRNS), Agile Therapeutics (AGRX), Summit Therapeutics PLC (SMMT), Majesco Entertainment Company (COOL), Viralytics (VRACY), Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), Organovo Holdings (ONVO), Vascular Biogenics (VBLT) and Adverum Biotechnologies (ADVM).
Who are Psychemedics Corporation's key executives?
Psychemedics Corporation's management team includes the folowing people:
- Raymond C. Kubacki Jr., Chairman of the Board, President, Chief Executive Officer
- Neil L. Lerner, Vice President - Finance
- Michael I. Schaffer Ph.D., Vice President - Laboratory Operations
- A. Clinton Allen, Independent Director
- Harry F. Connick Sr., Independent Director
- Walter S. Tomenson Jr., Independent Director
- Fred J. Weinert, Independent Director
How do I buy Psychemedics Corporation stock?
Shares of Psychemedics Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Psychemedics Corporation's stock price today?
One share of Psychemedics Corporation stock can currently be purchased for approximately $17.15.
MarketBeat Community Rating for Psychemedics Corporation (NASDAQ PMD)MarketBeat's community ratings are surveys of what our community members think about Psychemedics Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Psychemedics Corporation (NASDAQ:PMD) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | N/A |
Consensus Price Target History for Psychemedics Corporation (NASDAQ:PMD)
Analysts' Ratings History for Psychemedics Corporation (NASDAQ:PMD)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Psychemedics Corporation (NASDAQ:PMD)Earnings History by Quarter for Psychemedics Corporation (NASDAQ PMD)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/24/2017 | | | | | | | N/A |  |
| 8/2/2017 | Q2 2017 | | $0.16 | | $9.68 million | View | N/A | |
| 4/25/2017 | Q1 2017 | | $0.27 | | $10.21 million | View | N/A | |
| 2/10/2015 | Q414 | $0.08 | $0.13 | | $6.80 million | View | N/A | |
| 7/28/2014 | | $0.03 | $0.16 | | $7.69 million | View | N/A | |
| 4/29/2014 | Q114 | $0.12 | $0.14 | $6.40 million | $7.00 million | View | N/A | |
| 2/10/2014 | Q4 | | $0.16 | | | View | N/A | |
| 10/28/2013 | Q313 | | $0.20 | | | View | N/A | |
| 2/25/2013 | Q4 2012 | | $0.05 | $5.55 million | $5.66 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Psychemedics Corporation (NASDAQ:PMD)No earnings estimates for this company have been tracked by MarketBeat.com
Current Dividend Information for Psychemedics Corporation (NASDAQ:PMD)| Most Recent Dividend: | 8/24/2017 |
| Annual Dividend: | $0.60 |
| Dividend Yield: | 3.50% |
| Payout Ratio: | 44.44% (Trailing 12 Months of Earnings)
|
Dividend History by Quarter for Psychemedics Corporation (NASDAQ PMD)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 8/3/2017 | quarterly | $0.15 | 2.82% | 8/10/2017 | 8/14/2017 | 8/24/2017 |
| 4/26/2017 | quarterly | $0.15 | 3.08% | 5/4/2017 | 5/8/2017 | 5/18/2017 |
| 2/6/2017 | Quarterly | $0.15 | 2.89% | 2/14/2017 | 2/16/2017 | 2/27/2017 |
| 10/27/2016 | quarterly | $0.15 | 2.62% | 11/3/2016 | 11/7/2016 | 11/17/2016 |
| 7/27/2016 | quarterly | $0.15 | 3.29% | 8/3/2016 | 8/5/2016 | 8/15/2016 |
| 4/27/2016 | quarterly | $0.15 | 4.15% | 5/4/2016 | 5/6/2016 | 5/18/2016 |
| 2/11/2016 | quarterly | $0.15 | 5.75% | 2/18/2016 | 2/22/2016 | 3/4/2016 |
| 10/29/2015 | quarterly | $0.15 | 6.01% | 11/5/2015 | 11/9/2015 | 11/19/2015 |
| 7/29/2015 | quarterly | $0.15 | 5.12% | 8/5/2015 | 8/7/2015 | 8/18/2015 |
| 4/28/2015 | quarterly | $0.15 | 3.71% | 5/6/2015 | 5/8/2015 | 5/18/2015 |
| 2/11/2015 | quarterly | $0.15 | 3.97% | 2/19/2015 | 2/23/2015 | 3/6/2015 |
| 10/30/2014 | quarterly | $0.15 | 4.17% | 11/6/2014 | 11/10/2014 | 11/20/2014 |
| 10/30/2014 | quarterly | $0.15 | | | 11/20/2014 | 11/10/2014 |
| 7/29/2014 | quarterly | $0.15 | 4.22% | 8/5/2014 | 8/7/2014 | 8/18/2014 |
| 4/29/2014 | quarterly | $0.15 | 3.81% | 5/7/2014 | 5/9/2014 | 5/19/2014 |
| 2/10/2014 | quarterly | $0.15 | 3.8% | 2/19/2014 | 2/21/2014 | 3/7/2014 |
| 10/28/2013 | quarterly | $0.15 | 4.28% | 11/6/2013 | 11/11/2013 | 11/22/2013 |
| 8/5/2013 | quarterly | $0.15 | 4.68% | 8/13/2013 | 8/15/2013 | 8/28/2013 |
| 5/7/2013 | quarterly | $0.15 | 5.34% | 5/15/2013 | 5/17/2013 | 5/30/2013 |
| 2/25/2013 | quarterly | $0.15 | 4.98% | 3/5/2013 | 3/7/2013 | 3/21/2013 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Psychemedics Corporation (NASDAQ:PMD)Insider Ownership Percentage: 8.60%
Institutional Ownership Percentage: 57.95%
Insider Trades by Quarter for Psychemedics Corporation (NASDAQ:PMD)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/6/2017 | Michael I Schaffer | VP | Sell | 7,548 | $20.41 | $154,054.68 | |
| 9/5/2017 | Michael I Schaffer | VP | Sell | 4,400 | $20.37 | $89,628.00 | |
| 9/1/2017 | Michael I Schaffer | VP | Sell | 981 | $21.16 | $20,757.96 | |
| 3/9/2017 | James V Dyke | VP | Sell | 10,513 | $20.56 | $216,147.28 | |
| 12/14/2016 | James V Dyke | VP | Sell | 5,091 | $22.83 | $116,227.53 | |
| 12/9/2016 | Fred J Weinert | Director | Sell | 4,601 | $24.45 | $112,494.45 | |
| 11/18/2016 | Neil Lerner | VP | Sell | 3,000 | $24.75 | $74,250.00 | |
| 11/15/2016 | James V Dyke | VP | Sell | 10,000 | $23.56 | $235,600.00 | |
| 3/2/2016 | Harry F Sr Connick Sr | Director | Buy | 700 | $12.83 | $8,981.00 | |
| 2/26/2016 | Harry F Sr Connick Sr | Director | Buy | 1,000 | $12.63 | $12,630.00 | |
| 2/24/2016 | Harry F Sr Connick Sr | Director | Buy | 2,000 | $12.36 | $24,720.00 | |
| 2/22/2016 | Harry F Sr Connick Sr | Director | Buy | 1,000 | $12.61 | $12,610.00 | |
| 2/19/2016 | Harry F Sr Connick Sr | Director | Buy | 1,000 | $11.95 | $11,950.00 | |
| 2/16/2016 | Michael I Schaffer | VP | Buy | 4,507 | $11.09 | $49,982.63 | |
| 9/14/2015 | Raymond C. Kubacki, Jr. | CEO | Buy | 2,000 | $10.12 | $20,240.00 | |
| 9/10/2015 | Neil Lerner | VP | Buy | 3,000 | $10.32 | $30,960.00 | |
| 6/16/2015 | Michael I Schaffer | VP | Sell | 2,837 | $14.62 | $41,476.94 | |
(Data available from 1/1/2013 forward)
Headline Trends for Psychemedics Corporation (NASDAQ:PMD)
Latest Headlines for Psychemedics Corporation (NASDAQ:PMD)
| Source: |
|
| Date | Headline |
|---|
 | Does Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?
finance.yahoo.com - October 3 at 10:52 AM |
 | Psychemedics (PMD) Announces Addition of FDA-Cleared Benzodiazepines Hair Test
www.streetinsider.com - September 27 at 11:00 PM |
| Psychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test
finance.yahoo.com - September 27 at 11:00 PM |
 | Insider Selling: Psychemedics Corporation (PMD) VP Sells 981 Shares of Stock
www.americanbankingnews.com - September 6 at 9:38 PM |
| Michael I. Schaffer Sells 4,400 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 9:16 PM |
| Michael I. Schaffer Sells 7,548 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 8:50 PM |
| ETFs with exposure to Psychemedics Corp. : August 21, 2017
finance.yahoo.com - August 22 at 8:29 PM |
| Psychemedics Corporation Launches Synthetic Cannabinoids Hair Test
finance.yahoo.com - August 22 at 3:27 PM |
| Psychemedics Corporation - First Lab Approved For Hair Testing In Iowa
finance.yahoo.com - August 17 at 6:57 AM |
| Psychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017
finance.yahoo.com - August 10 at 6:58 AM |
| Psychemedics Corporation (NASDAQ:PMD) to Issue $0.15 Quarterly Dividend
www.americanbankingnews.com - August 3 at 6:20 PM |
| Psychemedics Corporation Announces Q2 Earnings
finance.yahoo.com - August 3 at 7:00 AM |
| Psychemedics posts 2Q profit
finance.yahoo.com - August 3 at 7:00 AM |
| Psychemedics Corporation (NASDAQ:PMD) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - July 22 at 10:23 AM |
 | Psychemedics posts 1Q profit
marketbeat.com - April 25 at 5:52 PM |
 | Psychemedics Corp: It's Not A Short
seekingalpha.com - March 27 at 9:41 AM |
| The Royce Funds: An Analysis Of Particularly Interesting Holdings
seekingalpha.com - March 25 at 8:44 AM |
 | DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 24 at 7:08 PM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 21 at 10:54 AM |
 | SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Psychemedics Corporation To Contact The Firm Before Lead Plaintiff Deadline
feeds.benzinga.com - March 15 at 9:33 PM |
| SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 15 at 7:27 PM |
| DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact The Firm
us.rd.yahoo.com - March 11 at 2:04 AM |
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 11 at 2:04 AM |
| PSYCHEMEDICS CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 7 at 7:08 PM |
| PMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Psychemedics Corporation and a Lead Plaintiff Deadline of April 3, 2017
us.rd.yahoo.com - February 28 at 7:59 PM |
| SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 28 at 7:59 PM |
| SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
us.rd.yahoo.com - February 28 at 7:59 PM |
| SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - February 21 at 5:36 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline – PMD
feeds.benzinga.com - February 17 at 9:51 PM |
| INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation
feeds.benzinga.com - February 17 at 11:12 AM |
| Glancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Psychemedics Corporation Investors and Encourages Investors to Contact the Firm
us.rd.yahoo.com - February 15 at 4:36 AM |
| INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
us.rd.yahoo.com - February 15 at 4:36 AM |
| SHAREHOLDER ALERT: Levi & Korsinsky, LLP Files in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation Sets Lead Plaintiff Deadline of April 3, 2017 -- PMD
us.rd.yahoo.com - February 13 at 11:23 PM |
| EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 11 at 1:33 AM |
| EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 11 at 1:33 AM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline - PMD
us.rd.yahoo.com - February 11 at 1:33 AM |
| SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline
feeds.benzinga.com - February 7 at 2:55 PM |
| IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces an Investigation of Psychemedics Corporation and Encourages Investors to Contact the Firm
us.rd.yahoo.com - February 6 at 7:22 PM |
| Psychemedics Corporation Announces Record Revenues And Earnings
us.rd.yahoo.com - February 6 at 7:22 PM |
Psychemedics Corporation (PMD) Chart for Tuesday, October, 17, 2017
